Skip to main content

Table 1 Number of infections in the year preceding the study

From: Clinical efficacy and tolerability of an immune-stimulant* constituted by inactivated bacterial bodies in the prophylaxis of infectious episodes of airways: a double blind, placebo-controlled, randomized, multicentre study

 

Placebo

Treated

2

10 (11.4)

11 (12.2)

3

28 (31.8)

22 (24.4)

4

24 (27.3)

20 (22.2)

5

12 (13.6)

18 (20.0)

6

14 (15.9)

19 (21.1)